Fei Gao Selected Research

Caspase 3 (Caspase-3)

1/2023	Analysis of Pharmacological Activities and Mechanisms of Essential Oil in Leaves of C. grandis 'Tomentosa' by GC-MS/MS and Network Pharmacology.
8/2021	Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
2/2017	Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma.
5/2015	P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
2/2015	[Mechanisms of sorafenib induced NB4 cell apoptosis].
6/2012	[Effect of liraglutide on interleukin-1β expression in the pancreatic islets of OLETF rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei Gao Research Topics

Disease

211	Neoplasms (Cancer) 05/2024 - 02/2002
70	Inflammation (Inflammations) 04/2024 - 01/2003
52	Infections 02/2024 - 01/2003
37	Neoplasm Metastasis (Metastasis) 05/2024 - 04/2004
35	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2004
31	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 07/2006
25	Myocardial Infarction 05/2024 - 11/2010
23	Type 2 Diabetes Mellitus (MODY) 11/2023 - 02/2008
22	Atherosclerosis 04/2024 - 11/2010
19	Fibrosis (Cirrhosis) 01/2024 - 06/2007
19	Ulcerative Colitis 12/2023 - 11/2020
18	Stroke (Strokes) 05/2024 - 01/2011
18	COVID-19 04/2024 - 01/2020
18	Hemorrhage 03/2024 - 11/2008
18	Cognitive Dysfunction 01/2024 - 10/2012
18	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2006
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 06/2008
14	Obesity 01/2024 - 01/2012
14	Pain (Aches) 01/2024 - 12/2006
14	Carcinoma (Carcinomatosis) 09/2023 - 02/2002
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2011
12	Glioma (Gliomas) 04/2023 - 05/2006
12	Uveitis 12/2022 - 12/2007
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024 - 01/2010
11	Hypertension (High Blood Pressure) 01/2023 - 01/2011
11	Carcinogenesis 01/2023 - 05/2008
10	Colitis 04/2024 - 01/2020
10	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 09/2007
10	Hyperglycemia 03/2024 - 02/2012
10	Acute Coronary Syndrome 01/2024 - 11/2011
10	Insulin Resistance 12/2023 - 01/2011
10	Wounds and Injuries (Trauma) 11/2023 - 01/2017
10	Thrombosis (Thrombus) 10/2022 - 07/2012
10	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2012
10	Atherosclerotic Plaque (Atheroma) 01/2016 - 07/2009
9	Asthma (Bronchial Asthma) 03/2024 - 01/2012
9	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2011
9	Heart Failure 03/2024 - 01/2016
9	Hypoxia (Hypoxemia) 12/2023 - 02/2014
9	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2011
9	Body Weight (Weight, Body) 08/2022 - 06/2013
8	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 05/2007
8	Diabetes Mellitus 12/2023 - 02/2011
8	Neuroinflammatory Diseases 12/2023 - 01/2011
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2013
8	Ischemia 01/2023 - 12/2015
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 03/2019

Drug/Important Bio-Agent (IBA)

86	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2003
46	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2003
33	Messenger RNA (mRNA)IBA 04/2024 - 10/2003
28	CytokinesIBA 01/2024 - 06/2007
27	VaccinesIBA 02/2024 - 04/2013
26	EnzymesIBA 01/2024 - 02/2008
25	Therapeutic UsesIBA 01/2024 - 10/2008
25	LipidsIBA 12/2023 - 02/2010
24	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2011
20	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2012
20	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 02/2008
19	Small Interfering RNA (siRNA)IBA 11/2022 - 11/2006
18	Transcription Factors (Transcription Factor)IBA 03/2024 - 08/2006
17	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2002
15	gamma-Aminobutyric Acid (GABA)IBA 05/2024 - 09/2013
15	AntibodiesIBA 02/2024 - 07/2011
15	InterferonsIBA 02/2023 - 02/2013
14	CateninsIBA 04/2023 - 12/2011
14	Long Noncoding RNAIBA 04/2023 - 09/2014
14	CollagenIBA 01/2022 - 06/2007
13	AntioxidantsIBA 01/2024 - 06/2007
12	AntigensIBA 01/2023 - 05/2006
12	Apolipoproteins E (ApoE)IBA 01/2023 - 11/2010
11	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 03/2009
11	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2001
10	LipopolysaccharidesIBA 03/2024 - 07/2013
10	oxidized low density lipoproteinIBA 12/2023 - 05/2012
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 10/2006
10	Antiviral Agents (Antivirals)IBA 04/2023 - 01/2015
10	Insulin (Novolin)FDA Link 10/2022 - 04/2015
9	HydrogelsIBA 05/2024 - 04/2016
9	Polysaccharides (Glycans)IBA 04/2024 - 09/2012
9	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2011
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 12/2006
9	Monoclonal AntibodiesIBA 08/2023 - 05/2007
9	Neuroprotective AgentsIBA 01/2023 - 08/2012
9	Peptides (Polypeptides)IBA 01/2023 - 01/2016
8	InterleukinsIBA 12/2023 - 05/2012
8	Retinaldehyde (Retinal)IBA 01/2023 - 01/2010
8	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 06/2008

Therapy/Procedure

109	Therapeutics 05/2024 - 01/2006
35	Drug Therapy (Chemotherapy) 12/2022 - 12/2006
20	Percutaneous Coronary Intervention 05/2024 - 01/2011
18	Radiotherapy 05/2021 - 04/2006
17	Brachytherapy 04/2023 - 02/2013
12	Transplantation 01/2023 - 07/2012
11	Aftercare (After-Treatment) 01/2024 - 12/2008
10	Immunotherapy 04/2024 - 10/2007
9	Hematopoietic Stem Cell Transplantation 03/2024 - 04/2018
9	Stents 04/2023 - 11/2008
8	Oral Administration 10/2023 - 01/2014
8	Injections 11/2020 - 01/2014